CN1236791C - 中药溃疡性结肠炎定位制剂 - Google Patents
中药溃疡性结肠炎定位制剂 Download PDFInfo
- Publication number
- CN1236791C CN1236791C CNB011434465A CN01143446A CN1236791C CN 1236791 C CN1236791 C CN 1236791C CN B011434465 A CNB011434465 A CN B011434465A CN 01143446 A CN01143446 A CN 01143446A CN 1236791 C CN1236791 C CN 1236791C
- Authority
- CN
- China
- Prior art keywords
- colon
- chinese medicine
- radix
- capsule
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 206010009900 Colitis ulcerative Diseases 0.000 title claims abstract description 23
- 201000006704 Ulcerative Colitis Diseases 0.000 title claims abstract description 23
- 210000001072 colon Anatomy 0.000 claims abstract description 31
- 239000002775 capsule Substances 0.000 claims abstract description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 210000002784 stomach Anatomy 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims description 21
- 239000011248 coating agent Substances 0.000 claims description 19
- 238000000576 coating method Methods 0.000 claims description 19
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000001419 dependent effect Effects 0.000 claims description 10
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 10
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- 229920003134 Eudragit® polymer Polymers 0.000 claims description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 8
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920000193 polymethacrylate Polymers 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000004925 Acrylic resin Substances 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 229920000178 Acrylic resin Polymers 0.000 claims description 5
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 5
- 239000009806 pulsatillae Substances 0.000 claims description 5
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 4
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- 239000001069 triethyl citrate Substances 0.000 claims description 4
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000013769 triethyl citrate Nutrition 0.000 claims description 4
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 15
- 241000792859 Enema Species 0.000 abstract description 5
- 239000007920 enema Substances 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 229940079360 enema for constipation Drugs 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 238000012856 packing Methods 0.000 description 10
- 238000001035 drying Methods 0.000 description 9
- 230000008685 targeting Effects 0.000 description 9
- 238000012946 outsourcing Methods 0.000 description 7
- 238000011068 loading method Methods 0.000 description 6
- 206010009887 colitis Diseases 0.000 description 5
- 229940095399 enema Drugs 0.000 description 4
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 4
- 229960004963 mesalazine Drugs 0.000 description 4
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229960002170 azathioprine Drugs 0.000 description 2
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 2
- 229960001940 sulfasalazine Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 102100033717 Retroviral-like aspartic protease 1 Human genes 0.000 description 1
- 101710188689 Small, acid-soluble spore protein 1 Proteins 0.000 description 1
- 101710188693 Small, acid-soluble spore protein 2 Proteins 0.000 description 1
- 101710166422 Small, acid-soluble spore protein A Proteins 0.000 description 1
- 101710166404 Small, acid-soluble spore protein C Proteins 0.000 description 1
- 101710174019 Small, acid-soluble spore protein C1 Proteins 0.000 description 1
- 101710174017 Small, acid-soluble spore protein C2 Proteins 0.000 description 1
- 101710174574 Small, acid-soluble spore protein gamma-type Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 1
- 229960004192 diphenoxylate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229940060037 fluorine Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000000321 herbal drug Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
药味 | 用量范围(g/日) |
苦参 | 4.5-9 |
地榆 | 9-15 |
白及 | 6-15 |
青黛 | 1.5-3 |
甘草 | 3-6 |
五倍子 | 3-6 |
黄芪 | 9-30 |
乌梅 | 6-12 |
黄连 | 2-5 |
白头翁 | 9-15 |
蒲公英 | 9-15 |
黄柏 | 2-12 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011434465A CN1236791C (zh) | 2001-12-28 | 2001-12-28 | 中药溃疡性结肠炎定位制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011434465A CN1236791C (zh) | 2001-12-28 | 2001-12-28 | 中药溃疡性结肠炎定位制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1428165A CN1428165A (zh) | 2003-07-09 |
CN1236791C true CN1236791C (zh) | 2006-01-18 |
Family
ID=4677165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011434465A Expired - Lifetime CN1236791C (zh) | 2001-12-28 | 2001-12-28 | 中药溃疡性结肠炎定位制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1236791C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102749224A (zh) * | 2012-06-18 | 2012-10-24 | 东南大学 | 负压吸入式疏浚泥浆取样器及取样方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181356B (zh) * | 2007-12-06 | 2010-11-10 | 张治中 | 一种治疗消化系统溃疡的中药制剂及其制备方法 |
CN101874853B (zh) * | 2010-05-31 | 2014-01-22 | 沈阳药科大学 | 一种治疗溃疡性结肠炎的丸剂及其制备工艺 |
CN102488775B (zh) * | 2011-12-28 | 2014-03-26 | 段支前 | 一种治疗痔疮的中药洗剂及其制备方法 |
CN102697926B (zh) * | 2012-06-12 | 2013-11-27 | 查迅 | 治疗溃疡性结肠炎的中药软膏及其制备方法 |
CN103316115A (zh) * | 2013-07-12 | 2013-09-25 | 石强 | 一种中药组合物及其制备方法 |
CN104689080B (zh) * | 2015-04-01 | 2018-03-09 | 江苏省中医院 | 一种灌肠治疗溃疡性结肠炎的复方药物及其制备方法与应用 |
CN106038752A (zh) * | 2016-07-28 | 2016-10-26 | 成都乾坤动物药业股份有限公司 | 一种辅助治疗动物出血性肠炎的药物组合物及其制备方法和用途 |
CN107875211B (zh) * | 2016-09-30 | 2021-01-05 | 北京中医药大学东方医院 | 一种用于治疗溃疡性结肠炎的组合物及其制备方法和应用 |
CN107929542A (zh) * | 2017-11-29 | 2018-04-20 | 赵文萃 | 补脾中药组合物及其制备方法 |
CN108721507A (zh) * | 2018-08-15 | 2018-11-02 | 钟建增 | 一种治疗慢性结肠炎的中药及其制备方法 |
CN111419980B (zh) * | 2020-03-26 | 2021-11-05 | 汉中市中医医院 | 药物组合物、制备方法、液体药剂、应用 |
CN111228390A (zh) * | 2020-03-28 | 2020-06-05 | 西安医学院附属宝鸡医院 | 一种止泻用中药组合物及其制备方法、液体药剂和应用 |
CN111840395A (zh) * | 2020-06-16 | 2020-10-30 | 张家港市中医医院 | 一种用于治疗溃疡性结肠炎的中药组合物 |
CN116211992B (zh) * | 2023-03-22 | 2023-11-21 | 重庆市中医院 | 一种用于治疗溃疡性结肠炎诱发抑郁样行为的中药组合物 |
-
2001
- 2001-12-28 CN CNB011434465A patent/CN1236791C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102749224A (zh) * | 2012-06-18 | 2012-10-24 | 东南大学 | 负压吸入式疏浚泥浆取样器及取样方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1428165A (zh) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1236791C (zh) | 中药溃疡性结肠炎定位制剂 | |
CN102940779B (zh) | 一种治疗慢性溃疡性结肠炎的药物组合物及其制备方法 | |
CN100464778C (zh) | 治疗胃溃疡、十二指肠溃疡的药 | |
CN1298730A (zh) | 一种妇科千金胶囊的制作工艺 | |
CN100493585C (zh) | 一种治疗慢性盆腔炎、月经不调疾病的纯中药 | |
CN1323684C (zh) | 一种治疗痔疮、肛裂的中药组合物及其制备方法 | |
CN1381259A (zh) | 一种治疗直肠、肛门疾病的药物 | |
CN100335119C (zh) | 一种治疗肠炎的中药组合物 | |
CN1682909A (zh) | 一种治疗复发性口腔溃疡的中药组合物 | |
CN105288107B (zh) | 复方沙棘清咽组合物及其制备方法 | |
CN1088592C (zh) | 治疗消化性溃疡的药物 | |
CN116211992B (zh) | 一种用于治疗溃疡性结肠炎诱发抑郁样行为的中药组合物 | |
CN100353987C (zh) | 一种治疗痤疮的中药制剂 | |
CN101912570A (zh) | 一种治疗风湿病的药物组合物及其制备方法 | |
CN101496840B (zh) | 一种快速治疗牙痛的中药复方冲剂 | |
CN1193785C (zh) | 一种治疗风湿、类风湿疾病的药物 | |
CN1203098A (zh) | 一种治疗股骨头无菌性坏死的中药 | |
CN1091011A (zh) | 一种溶石降脂中药冲剂及制作方法 | |
CN105169326A (zh) | 一种冻疮膏 | |
Janugade et al. | Effect of PVP concentration on lag time of press-coated Montelukast sodium tablet | |
CN1559503A (zh) | 芒果止咳胶囊和长效胶囊的制备方法 | |
CN115554345A (zh) | 一种治疗痛风及高尿酸血症的中药复方制剂及其制法 | |
CN1179745C (zh) | 治疗结石及胆囊炎的中药制剂及其生产方法 | |
CN1569185A (zh) | 一种治疗痔疮的中药胶囊 | |
CN116098919A (zh) | 一种用于糖尿病肾病的组合物、制剂及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine positioning preparation for curing ulcerative colitis Effective date of registration: 20170614 Granted publication date: 20060118 Pledgee: Beijing ustron Tongsheng financing Company limited by guarantee Pledgor: Beijing Zhonghui Pharmaceutical Industry Co., Ltd. Registration number: 2017990000486 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200612 Granted publication date: 20060118 Pledgee: Beijing ustron Tongsheng financing Company limited by guarantee Pledgor: BEIJING ZHONGHUI PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: 2017990000486 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine positioning preparation for curing ulcerative colitis Effective date of registration: 20200617 Granted publication date: 20060118 Pledgee: Beijing ustron Tongsheng financing Company limited by guarantee Pledgor: BEIJING ZHONGHUI PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2020990000638 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20060118 |
|
CX01 | Expiry of patent term |